Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syndrome of Inappropriate ADH (SIADH) Secretion”

14 trials

Showing 14 of 14 results

Not applicableLooking for participantsNCT04790175
What this trial is testing

Samsca Post-marketing General Drug Use-results Survey in Patients with Hyponatremia in SIADH

Who this might be right for
Antidiuretic Hormone, Inappropriate Secretion
Otsuka Pharmaceutical Co., Ltd. 300
Testing effectiveness (Phase 2)Study completedNCT00032734
What this trial is testing

Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

Who this might be right for
Syndrome of Inappropriate ADH (SIADH) SecretionHyponatremia
Sanofi 35
Not applicableStudy completedNCT02548845
What this trial is testing

An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain

Who this might be right for
HyponatremiaSyndrome of Inappropriate ADH (SIADH) Secretion
Otsuka Pharmaceutical Europe Ltd 70
Not applicableStudy completedNCT04119206
What this trial is testing

Tolvaptan Versus Fluid Restriction in SIADH

Who this might be right for
HyponatremiaSyndrome of Inappropriate ADH (SIADH) SecretionPituitary
University of Erlangen-Nürnberg Medical School 334
Not applicableStudy completedNCT02545101
What this trial is testing

An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH

Who this might be right for
HyponatremiaSyndrome of Inappropriate ADH (SIADH) Secretion
Otsuka Pharmaceutical Europe Ltd 100
Large-scale testing (Phase 3)Study completedNCT00264927
What this trial is testing

Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

Who this might be right for
Inappropriate ADH SyndromeHyponatremia
Sanofi 77
Large-scale testing (Phase 3)Study completedNCT03048747
What this trial is testing

Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH

Who this might be right for
Syndrome of Inappropriate Antidiuretic Hormone Secretion
Otsuka Pharmaceutical Co., Ltd. 16
Not applicableLooking for participantsNCT06821802
What this trial is testing

Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis

Who this might be right for
HyponatremiaSyndrome of Inappropriate Antidiuresis
University Hospital, Basel, Switzerland 70
Large-scale testing (Phase 3)Study completedNCT00264914
What this trial is testing

Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

Who this might be right for
Inappropriate ADH SyndromeHyponatremia
Sanofi 57
Not applicableStudy completedNCT02573077
What this trial is testing

An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy

Who this might be right for
HyponatremiaSyndrome of Inappropriate ADH (SIADH) SecretionCancer
Otsuka Pharmaceutical Europe Ltd 69
Post-approval studies (Phase 4)WithdrawnNCT00298753
What this trial is testing

Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine

Who this might be right for
Syndrome of Inappropriate ADH-secretion
Regional Hospital Holstebro
Testing effectiveness (Phase 2)Study completedNCT02009878
What this trial is testing

A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

Who this might be right for
Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Not applicableStudy completedNCT01341665
What this trial is testing

Subclassification of the Syndrome of Inappropriate ADH Secretion

Who this might be right for
Hyponatremia
University of Wuerzburg 50
Large-scale testing (Phase 3)Ended earlyNCT00728091
What this trial is testing

A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia

Who this might be right for
HyponatremiaInappropriate ADH Syndrome
Sanofi 2

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation